miR-139 inhibits osteosarcoma cell proliferation and invasion by targeting ROCK1

被引:8
|
作者
Fan, Gentao [1 ]
He, Zhiwei [1 ]
Cao, Lili [1 ]
Shi, Xin [1 ]
Wu, Sujia [1 ]
Zhou, Guangxin [1 ]
机构
[1] Jinling Hosp, Dept Orthoped, Nanjing 210002, Jiangsu, Peoples R China
来源
关键词
Osteosarcoma; miR-139; ROCK1; Proliferation; Invasion; EPITHELIAL-MESENCHYMAL TRANSITION; COLORECTAL-CANCER; DOWN-REGULATION; MIGRATION; METASTASIS; APOPTOSIS; MICRORNAS; REGULATOR; GROWTH;
D O I
10.2741/4773
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
miR-139 has a tumor suppressor effect in many tumors. Here, we examined the suppressive role of this miRNA and its target, ROCK1, in osteosarcoma (OS), a highly malignant bone tumor that mainly affects children and adolescents. The expression of miR-139 was down-regulated in OS. Overexpression of miR-139 significantly inhibited OS cell proliferation, migration, and invasion. Ectopic expression of miR139 down-regulated ROCK1, a target of miR-139, by direct binding to its 3' untranslated region (3'UTR). Direct siRNA-mediated silencing of ROCK1 exerted an inhibitory effect on OS cell proliferation and invasion similar to the effect of miR-139. ROCK1 transfection reversed the suppressive effect of miR-139 on OS cell proliferation and invasion. Both miR-139 and siRNA knockdown of ROCK1 significantly downregulated beta-CATENIN and p-AKT and up-regulated E-CADHERIN and p53. The data provided here show that miR-139 exerts suppressive effects on proliferation and invasion of OS cells by targeting ROCK1.
引用
收藏
页码:1167 / 1177
页数:11
相关论文
共 50 条
  • [31] MiR-539 inhibits cell proliferation and invasion by targeting CARMA1 in NSCLC
    Zhou, Dongbo
    He, Baimei
    Gao, Ying
    Yu, Qiao
    Chen, Qiong
    He, Bixiu
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (02): : 1460 - 1466
  • [32] MicroRNA-133b Inhibits Cell Proliferation and Invasion in Osteosarcoma by Targeting Sirt1
    Shi Ying
    Huang Jianjun
    Yi Xue
    Yu Shuwei
    Zhang Liyuan
    Wang Jie
    Cheng Lixian
    ONCOLOGY RESEARCH, 2017, 25 (09) : 1421 - 1430
  • [33] miR-423-5p Inhibits Osteosarcoma Proliferation and Invasion Through Directly Targeting STMN1
    Wang, Xuesong
    Peng, Lei
    Gong, Xiaojin
    Zhang, Xiugong
    Sun, Ruifu
    Du, Jinlong
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2018, 50 (06) : 2249 - 2259
  • [34] Regulation of RAP1B by miR-139 suppresses human colorectal carcinoma cell proliferation
    Guo, Haiyan
    Hu, Xiaobo
    Ge, Shengfang
    Qian, Guanxiang
    Zhang, Jianjun
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2012, 44 (09): : 1465 - 1472
  • [35] MiR-659-3p inhibits osteosarcoma progression and metastasis by inhibiting cell proliferation and invasion via targeting SRPK1
    Gong, Yubao
    Wei, Zheng-Ren
    BMC CANCER, 2022, 22 (01)
  • [36] MiR-659-3p inhibits osteosarcoma progression and metastasis by inhibiting cell proliferation and invasion via targeting SRPK1
    Yubao Gong
    Zheng-Ren Wei
    BMC Cancer, 22
  • [37] Silencing Drp1 inhibits glioma cells proliferation and invasion by RHOA/ROCK1 pathway
    Yin, Maojia
    Lu, Qin
    Liu, Xi
    Wang, Teng
    Liu, Ying
    Chen, Lifen
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2016, 478 (02) : 663 - 668
  • [38] RETRACTED: miR-150 is downregulated in osteosarcoma and suppresses cell proliferation, migration and invasion by targeting ROCK1 (Retracted article. See vol. 24, pg. 342, 2022)
    Li, Chang-Hui
    Yu, Teng-Bo
    Qiu, Hong-Wei
    Zhao, Xia
    Zhou, Chuan-Li
    Qi, Chao
    ONCOLOGY LETTERS, 2017, 13 (04) : 2191 - 2197
  • [39] LncRNA XIST regulates cell proliferation, migration and invasion of glioblastoma via regulating miR-448 and ROCK1
    Li, H. L.
    Han, P. H.
    Pan, D. Q.
    Chen, G.
    Lu, X. H.
    Li, J.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2020, 34 (06): : 2049 - 2058
  • [40] Mir-139-5p inhibits glioma cell proliferation and progression by targeting GABRA1
    Lei Wang
    Yan Liu
    Zhengtao Yu
    Jianwu Gong
    Zhiyong Deng
    Nianjun Ren
    Zhe Zhong
    Hao Cai
    Zhi Tang
    Haofeng Cheng
    Shuai Chen
    Zhengwen He
    Journal of Translational Medicine, 19